The primary cause of Huntington's disease (HD) is expression of huntingtin with a
polyglutamine expansion. Despite an absence of consensus on the mechanism(s) of toxicity, …

P/Q-type voltage-gated calcium channels are regulated, in part, through the cytoplasmic C-terminus
of their α1A subunit. Genetic absence or alteration of the C-terminus leads to …

Background Huntington’s disease is an autosomal-dominant neurodegenerative disease
caused by CAG trinucleotide repeat expansion in HTT, resulting in a mutant huntingtin protein. …

Transactivating response region DNA binding protein (TDP-43) is the major protein
component of ubiquitinated inclusions found in amyotrophic lateral sclerosis (ALS) and …

Accumulation of hyperphosphorylated tau directly correlates with cognitive decline in
Alzheimer’s disease and other primary tauopathies. One therapeutic strategy may be to reduce …

Mutant huntingtin (HTT) protein causes Huntington disease (HD), an incurable neurological
disorder. Silencing mutant HTT using nucleic acids would eliminate the root cause of HD. …

Mutations in superoxide dismutase 1 (SOD1) are responsible for 20% of familial ALS. Given
the gain of toxic function in this dominantly inherited disease, lowering SOD1 mRNA and …

No treatments exist to slow or halt Parkinson's disease (PD) progression; however, inhibition
of leucine-rich repeat kinase 2 (LRRK2) activity represents one of the most promising …

The genetic basis for most inherited neurodegenerative diseases has been identified, yet
there are limited disease-modifying therapies for these patients. A new class of drugs—…

Charcot-Marie-Tooth disease type 1A (CMT1A) is caused by duplication of peripheral myelin
protein 22 (PMP22) and is the most common hereditary peripheral neuropathy. CMT1A is …